Literature DB >> 9146761

Review article: controversy in the therapy of gastro-oesophageal reflux disease--long-term proton pump inhibition or laparoscopic anti-reflux surgery?

S J Walker1, S T Baxter, A I Morris, R Sutton.   

Abstract

The treatment of gastro-oesophageal reflux disease is controversial. Whilst medical treatment is successful in patients with mild to moderate disease, the threshold of severity above which an operation should be contemplated remains a matter for debate. Laparoscopic anti-reflux surgery may be lowering this threshold, as this form of therapy provides several advantages over its open counterpart, but it is not without risk, and few long-term results are available. This article reviews treatment options for reflux disease and examines the relative position of current medical and surgical therapies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146761     DOI: 10.1046/j.1365-2036.1997.152327000.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Endoscopic treatment for gastroesophageal reflux disease: should you learn the techniques?

Authors:  Julia J Liu
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

2.  Quality of life in GERD patients: medical treatment versus antireflux surgery.

Authors:  Ruxandra Ciovica; Michael Gadenstätter; Anton Klingler; Wolfgang Lechner; Otto Riedl; Gerhard P Schwab
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

3.  A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease.

Authors:  Ayman M Abdel Aziz; Hisham R El-Khayat; Ahmed Sadek; Samer G Mattar; Gail McNulty; Pradermchai Kongkam; Mohamed F Guda; Glen A Lehman
Journal:  Surg Endosc       Date:  2010-04       Impact factor: 4.584

Review 4.  Refractory gastro-oesophageal reflux disease: diagnosis and management.

Authors:  Julia J Liu; John R Saltzman
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.